Status:

UNKNOWN

Outcome of COVID-19 Cases Based on Tuberculin Test: Can Previous BCG Alter the Prognosis?

Lead Sponsor:

Assiut University

Conditions:

COVID-19

BCG Vaccination

Eligibility:

All Genders

12-80 years

Brief Summary

There is no evidence that the Bacille Calmette-Guérin vaccine (BCG) protects people against infection with COVID-19 virus. Two clinical trials addressing this question are underway, and WHO will evalu...

Eligibility Criteria

Inclusion

  • COVID-19 positive cases admitted to hospitals in Upper Egypt

Exclusion

  • None

Key Trial Info

Start Date :

April 11 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 30 2020

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT04347876

Start Date

April 11 2020

End Date

June 30 2020

Last Update

April 15 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

AssiutU

Asyut, Egypt, 71111